Extensions

To provide a detailed analysis of US patent 12110089, I will search the USPTO database for information regarding patent term adjustments (PTA), patent term extensions (PTE), continuation applications, divisional applications, related family members, and its projected expiration date.

Patent Term Adjustments (PTA) and Extensions (PTE)

Based on the provided information, US Patent 12110089 was filed on 2023-06-16 and issued on 2024-10-08.

Patent Term Adjustment (PTA) is granted to compensate applicants for certain delays caused by the USPTO during the patent examination process. These delays can include the USPTO failing to:

• Issue a first office action or notice of allowance within 14 months of filing.
• Respond to an applicant's reply within four months.
• Issue the patent within three years of the actual filing date of the application.
• Issue the patent within four months of payment of the issue fee.

Patent Term Extension (PTE) is available for patents claiming products (such as human drugs, food additives, medical devices, etc.) that require premarket regulatory review by a government agency, like the FDA, to restore time lost during this approval process.

The provided patent information does not explicitly state whether any Patent Term Adjustments (PTA) or Patent Term Extensions (PTE) were granted for US12110089. Typically, PTA calculations are included in the Issue Notification Letter and are indicated on the patent itself at the time of issuance. To determine the exact PTA, if any, and its impact on the expiration date, one would usually need to consult the patent's official file wrapper in Patent Center or the issue notification. The patent also does not appear to be related to products subject to regulatory review that would qualify for PTE.

Continuation and Divisional Applications

• Continuation Applications (CON): A continuation application shares the exact same disclosure as its parent but pursues different claims, and no new subject matter may be added. The continuation must be filed while the parent application is still pending (i.e., before it issues or is abandoned).
• Divisional Applications (DIV): A divisional application arises when the USPTO issues a restriction requirement, determining that a single application contains two or more independent and distinct inventions. The applicant can then elect one invention to prosecute in the parent and file a divisional for the other(s). A divisional application is limited to claiming only an invention or inventions disclosed and claimed in the prior-filed application that were subject to a restriction requirement and not elected for examination. The safe harbor provision of 35 U.S.C. § 121, which protects against double patenting rejections, applies only to divisional applications and not to continuation applications or continuation-in-part applications.

According to the provided information, US12110089 is explicitly listed as having two "Priority Applications" and one "Related Child Application" and one "Related Parent Applications":

• US18/211,036: This is listed as the application number for US12110089, with a priority date of 2020-12-17 and a filing date of 2023-06-16. This is the application from which the patent directly issued.
• US18/824,639: This is listed as a "Priority Application" and also a "Related Child Application" with a priority date of 2020-12-17 and a filing date of 2024-09-04. This implies that US18/824,639 (which corresponds to publication US20240425162A1) is a continuing application of some sort, likely a continuation or divisional, claiming priority back to the same earliest filing date as US12110089.
• PCT/IB2021/061985: This is listed as a "Priority Application" and also a "Related Parent Application" with a priority date of 2020-12-17 and a filing date of 2021-12-17. US12110089 is noted as a "by-pass continuation filing under 35 U.S.C. 111 of International Application No. PCT/IB2021/061985". This indicates that the US application for 12110089 is a continuation of the PCT application.

The patent family information also indicates a US Provisional Application No. 63/127,127, filed on 2020-12-17, from which PCT/IB2021/061985 claims benefit and priority. This provisional application appears to be the ultimate priority document for the entire family.

Related Family Members

The patent family includes:

• US12110089B2 (Issued Patent)
• US20230356820A1 (Publication of US18/211,036)
• US18/211,036 (Application for US12110089)
• US20240425162A1 (Publication of US18/824,639)
• US18/824,639 (Related application, possibly a continuation or divisional of US18/211,036 or the PCT)
• PCT/IB2021/061985 (International Application)
• WO2022130349A1 (Publication of PCT/IB2021/061985)
• US202063127127P (US Provisional Application)
• EP4277841B8 (European Patent)
• EP4277841A1 (European Publication)
• EP4277841A4 (European Publication)
• EP4277841B1 (European Patent)
• EP21905975.5A (European Application for EP4277841B8)
• EP25204080.3A (European Application)
• EP4671114A3 (European Publication)
• ES3031741T3 (Spanish Patent)
• ES3031741T1 (Spanish Patent)
• ES21905975T (Spanish Application for ES3031741T3)

Projected Expiration Date

The normal term of a U.S. patent is 20 years from the earliest claimed non-provisional filing date. In this case, the earliest priority date for US12110089 is 2020-12-17, from US Provisional Application No. 63/127,127.

Therefore, the anticipated expiration date for US12110089, without considering any PTA or PTE, is 2041-12-17. [cite: US12110089B2] The patent text itself explicitly states "Anticipated expiration 2041-12-17". [cite: US12110089B2]